7don MSN
Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher ...
11d
The Independent on MSNWhat are the symptoms of prostate cancer and how common is it?What are the symptoms of prostate cancer and how common is it? - Formula One team owner Eddie Jordan has died from the ...
Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...
A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer ...
According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...
19h
News Medical on MSNWorld first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in menThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.
Researchers used a double-pronged approach to reduce tumor growth in tissue samples of prostate cancer. A new study by University of Arizona Health Sciences researchers found that an immunotherapy ...
The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results